Aspiriant LLC’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,345
| Closed | -$266K | – | 266 |
|
|
2018
Q2 | $266K | Sell |
3,345
-1,211
| -27% | -$96.3K | 0.02% | 216 |
|
|
2018
Q1 | $406K | Buy |
+4,556
| New | +$406K | 0.04% | 162 |
|
|
2017
Q4 | – | Sell |
-9,014
| Closed | -$1.31M | – | 204 |
|
|
2017
Q3 | $1.31M | Sell |
9,014
-1,490
| -14% | -$217K | 0.11% | 93 |
|
|
2017
Q2 | $1.36M | Sell |
10,504
-1,744
| -14% | -$226K | 0.12% | 96 |
|
|
2017
Q1 | $1.52M | Buy |
12,248
+395
| +3% | +$49.1K | 0.13% | 96 |
|
|
2016
Q4 | $1.37M | Sell |
11,853
-119
| -1% | -$13.8K | 0.12% | 90 |
|
|
2016
Q3 | $1.25M | Buy |
+11,972
| New | +$1.25M | 0.12% | 93 |
|